PORTAL: Patient-reported Outcomes After Routine Treatment of Atypical Lesions
Condition(s):Breast CancerLast Updated:February 22, 2024Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Breast CancerLast Updated:February 22, 2024Active, not recruiting
Condition(s):Breast Haematoma; Breast Cancer; Breast DiseasesLast Updated:December 29, 2022Completed
Condition(s):Breast Cancer; Breast Neoplasms; Breast Cancer FemaleLast Updated:February 8, 2024Recruiting
Condition(s):Breast CancerLast Updated:March 31, 2020Completed
Condition(s):Estrogen Receptor Positive; HER2/Neu Negative; Invasive Breast Carcinoma; Multifocal Breast Carcinoma; Postmenopausal; Progesterone Receptor Positive; Stage I Breast Cancer; Stage IA Breast Cancer; Stage IB Breast Cancer; Stage II Breast Cancer; Stage IIA Breast Cancer; Stage IIB Breast Cancer; Stage III Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast CancerLast Updated:September 26, 2022Terminated
Condition(s):Breast CancerLast Updated:April 6, 2016Unknown status
Condition(s):Breast Cancer; Breast Tumors; Cancer of BreastLast Updated:August 30, 2023Completed
Condition(s):Stage I Breast Cancer; Stage II Breast Cancer; Stage III Breast Cancer; Invasive Breast CancerLast Updated:May 17, 2013Terminated
Condition(s):Breast NeoplasmsLast Updated:May 17, 2016Completed
Condition(s):Breast Cancer; Endometrial Cancer; Ovarian CancerLast Updated:September 10, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.